Executive Director, Regulatory CMC

Centessa Pharmaceuticals is a novel pharmaceutical company that employs a deconstructed R&D environment, emphasizing data-driven decision-making led by subject matter experts. Their asset-centric model minimizes centralized infrastructure and hierarchy, focusing on efficient capital allocation and rapid scientific inquiry. This approach aims to enhance program success rates with increased speed and reduced costs.